Results reveal that KIT antibody pretreatment significantly reduced the binding of KIT-d to GIST cells (Figure 2H), and conversely, high concentrations of KIT-d pre-treatment also significantly diminished the binding of the KIT antibody to GIST cells (Figure 2I). The gene discussed is KIT; the disease is gastrointestinal stromal tumor.